Evidence map›Paper›PMID 42307875›Full record

ArticleDiscover nano2026

Harnessing Tolypothrix sp. A-8 for biogenic synthesis of silver oxide nanoparticles (AgONPs) for multifunctional biomedical applications.

Muhammad Kaleem, Lubna Anjum Minhas, Amber Jabeen, Muhammad Abdullah, Ghulam Mustafa Bajwa, Hafiz Muhammad Umer Farooqi, Dovran Shamamedov, Abdul Samad Mumtaz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Muhammad KaleemPlants and Algal Genetics Laboratory, Department of Plant Sciences, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, 45320, Pakistan. mkaleem@bs.qau.edu.pk.
Lubna Anjum MinhasPlants and Algal Genetics Laboratory, Department of Plant Sciences, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, 45320, Pakistan.
Amber JabeenPlants and Algal Genetics Laboratory, Department of Plant Sciences, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, 45320, Pakistan.
Muhammad AbdullahMechanical Engineering Department, School of Environment and Sustainability, University of Michigan, Ann Arbor, MI, USA.
Ghulam Mustafa BajwaDepartment of Biochemistry and Biotechnology, Islamia University, Bahawalpur, Pakistan.
Hafiz Muhammad Umer FarooqiLaboratory for Energy Metabolism, Division of Metabolic Disorders, Children's Hospital of Orange County, Orange, CA, 92868, USA.
Dovran ShamamedovPlant Molecular Genetics Lab, Department of Applied Biosciences, Kyungpook National University, Daegu, South Korea.
Abdul Samad MumtazPlants and Algal Genetics Laboratory, Department of Plant Sciences, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, 45320, Pakistan. asmumtaz@qau.edu.pk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Green nanotechnology leverages biological systems for the sustainable synthesis of nanomaterials, offering an eco-friendly alternative to conventional methods. In this study, we report the phyco-synthesis of silver oxide nanoparticles (AgONPs) using an aqueous extract of Tolypothrix sp. A-8, a cyanobacterium rich in bioactive metabolites that serve as both reducing and capping agents. Synthesis was optimized by controlling key physicochemical parameters (reaction time, precursor concentration, temperature, and pH) to maximize yield. The resulting nanoparticles were comprehensively characterized using X-Ray Diffraction, Ultraviolet Visible Spectroscopy (UV), Fourier Transform Infrared Spectroscopy, Dynamic Light Scattering, Scanning Electron Microscopy, and Energy-Dispersive X-ray Spectroscopy. The AgONPs demonstrated significant anti-leishmanial activity, with IC

Indexed as

AnticancerAnti-inflammatoryBiocompatibility assessmentOptimization parametersSilver oxide nanoparticlesTolypothrix sp. A-8

Identifiers

PMID42307875
PMCPMC13275956

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.